Paydirt
Insider filing · SKYE

Andrew J. Schwab sold $770K of Skye Bioscience (SKYE)

Executed Aug 21 2025, disclosed Aug 22 2025, 1 day later.

Value, as filed
$770K
222,621 sh across 2 lots
Executed
Aug 21 2025
the trade date, as filed
Disclosed
Aug 22 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
purchases only

Returns are measured on stock purchases only.

The filer
AS Andrew J. Schwab Director profile →

Andrew J. Schwab (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27.

The name
SKYE SKYE SKYE · 6 filings in 24 months ticker → Insider filings, newest first View the original filing at www.sec.gov
Other filings by Andrew J. Schwab in SKYE
SKYESALE Skye Bioscience, Inc.
251,060 sh across 2 lots · price not plausible
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET